Castle Biosciences (CSTL) PT Lowered to $80 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Kyle Mikson lowered the price target on Castle Biosciences (NASDAQ: CSTL) to $80.00 (from $94.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
